China SXT PharmaceuticalsSTU:2RY1 48 Days Inventory is 380.06 as of Mar. 2026, which is 118% above its 10-year median of 174.56. GuruFocus rates STU:2RY1 with a GF Score™ of 48/100 and a GF Value™ of €320.00. The stock has 7 warning signs investors should review. Among 919 Drug Manufacturers companies, China SXT Pharmaceuticals ranks worse than 86.62% on this metric.
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
China SXT Pharmaceuticals's Inventory Turnover for the
six
months ended in Mar. 2026 was 0.48.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
China SXT Pharmaceuticals's Inventory-to-Revenue for the
six
months ended in Mar. 2026 was 1.48.
China SXT Pharmaceuticals (STU:2RY1) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
China SXT Pharmaceuticals's Inventory Turnover for the
six
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
China SXT Pharmaceuticals's Inventory to Revenue for the
six
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
China SXT Pharmaceuticals Days Inventory Related Terms
China SXT Pharmaceuticals Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:2RY1 vs CABR, BFRI, BIOE: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, China SXT Pharmaceuticals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China SXT Pharmaceuticals Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, China SXT Pharmaceuticals's Days Inventory distribution charts can be found below:
* The bar in red indicates where China SXT Pharmaceuticals's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China SXT Pharmaceuticals (STU:2RY1) has a Days Inventory of 380.06 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on China SXT Pharmaceuticals and its competitors. This is 118% above median its historical median of 174.56. Over the past decade, China SXT Pharmaceuticals' Days Inventory has ranged from 108.85 to 329.49. According to the industry distribution chart, China SXT Pharmaceuticals ranks #796 out of 919 companies in the Drug Manufacturers industry, placing it in the top 86.6%.
Is China SXT Pharmaceuticals' Days Inventory too high?
China SXT Pharmaceuticals' current Days Inventory of 380.06 is 118% above median its 10-year median of 174.56. Over the past 10 years, this metric has ranged from a low of 108.85 to a high of 329.49. The Drug Manufacturers industry median Days Inventory is 164.48. China SXT Pharmaceuticals' value of 380.06 is 131.1% above this industry median. Based on the distribution chart, China SXT Pharmaceuticals ranks #796 out of 919 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, China SXT Pharmaceuticals has a GF Score™ of 48/100, reflecting its overall financial health beyond just this single metric.
How does China SXT Pharmaceuticals' Days Inventory compare to CABR and BFRI?
According to the Drug Manufacturers industry distribution chart, China SXT Pharmaceuticals ranks #796 out of 919 companies for Days Inventory. This places China SXT Pharmaceuticals in the lower half of its industry. The industry median Days Inventory is 164.48. China SXT Pharmaceuticals' value of 380.06 is 131.1% above this benchmark. Historically, China SXT Pharmaceuticals' own Days Inventory has ranged from 108.85 to 329.49 over the past decade. While the company's 10-year median is 174.56 vs. the industry median of 164.48, China SXT Pharmaceuticals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 919 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China SXT Pharmaceuticals's current Days Inventory of 380.06 is 131.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on China SXT Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China SXT Pharmaceuticals's current Days Inventory is 380.06, which is 118% above median its own 10-year median of 174.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China SXT Pharmaceuticals stock overvalued right now?
China SXT Pharmaceuticals (STU:2RY1) has a current Days Inventory of 380.06. The stock's GF Value™ is €320.00, compared to a current price of €384.00 — trading 20% above its estimated fair value. The current Days Inventory is 380.06, which is 118% above median its 10-year median of 174.56 and 131.1% above the Drug Manufacturers industry median of 164.48. China SXT Pharmaceuticals' overall GF Score™ is 48/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For China SXT Pharmaceuticals (STU:2RY1), the current Days Inventory is 380.06 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China SXT Pharmaceuticals (STU:2RY1) Overvalued in 2026?
Based on GuruFocus' analysis, China SXT Pharmaceuticals stock appears to be overvalued.
The current stock price of €384.00 is trading 20% above its estimated GF Value™ of €320.00.
Key valuation signals for STU:2RY1:
Days Inventory: 380.06 (118% above median its 10-year median of 174.56)
GF Value™: €320.00 vs. price of €384.00 (20% above fair value)
Industry Position: 131.1% above the Drug Manufacturers median (#796 of 919)
No single metric tells the full story. See the STU:2RY1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
48GF Score
Get the complete analysis for STU:2RY1
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:2RY1 has been successfully added to your 
